ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $494,000 | -59.5% | 12,220 | -42.4% | 0.01% | -56.5% |
| Q2 2015 | $1,221,000 | -26.8% | 21,220 | -19.1% | 0.02% | -23.3% |
| Q1 2015 | $1,669,000 | +54.5% | 26,220 | +49.8% | 0.03% | +57.9% |
| Q4 2014 | $1,080,000 | +58.8% | 17,500 | 0.0% | 0.02% | +58.3% |
| Q3 2014 | $680,000 | +31.5% | 17,500 | +16.7% | 0.01% | +20.0% |
| Q2 2014 | $517,000 | -20.2% | 15,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $648,000 | +8.4% | 15,000 | 0.0% | 0.01% | +9.1% |
| Q4 2013 | $598,000 | -20.4% | 15,000 | -25.0% | 0.01% | -21.4% |
| Q3 2013 | $751,000 | +11.8% | 20,000 | -20.0% | 0.01% | +7.7% |
| Q2 2013 | $672,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |